Spectrum aims to increase annual turnover by more than 15% in 2023
Spectrum Ophthalmics aimed to increase annual turnover by more than 15% in 2023 with the addition of products and an expanded sales team.
The company said it had launched a number of new products, including a range of solutions for dry eye disease aimed at meeting the need of business to business and business to consumer groups.
David Killengray, managing director at Spectrum Ophthalmics, said: ‘Over the next 12 months we will continue to invest in our product range, unique support solutions and experienced team to provide ophthalmologists with the confidence to deliver the best eyecare solutions, treatments, advice and aftercare for their patients.’